Prof. Gordon Jayson, Consultant Medical Oncologist
Prof. Gordon Jayson
Consultant Medical Oncologist
Prof. Jayson is a Consultant Medical Oncologist
Areas of expertise
- Gynaecological cancers
- Ovarian cancer
- Endometrial cancer
- Uterus (womb) cancer
- Chemotherapy
Make an appointment
Address
-
The Christie Private Care
Wilmslow Road, Manchester, M20 4BX
About Prof. Gordon Jayson
GMC number: 3296981
Year qualified: 1988
Place of primary qualification: Oxford University
Prof. Gordon Jayson is a Consultant Medical Oncologist at The Christie and a Professor of Medical Oncology at the University of Manchester. He specialises in gynaecological oncology with a particular focus on ovarian and endometrial cancer.
After studying Medicine at the University of Oxford, Prof. Jayson completed his medical and oncology training, as well as his PhD, in Manchester. In 1997, he was appointed as a Senior Lecturer at The Christie and The University of Manchester. Over the years, he has served on several prestigious committees, including Cancer Research UK's New Agents Committee, the Medical Research Council's Drug and Device Development Committee, and the National Clinical Trials Committee. Currently, he is the Chair of Translational Research for the Medical Research Council ICON7 and the Manchester Cancer Systemic Anti-Cancer Therapy Board.
Prof. Jayson is deeply involved in research, particularly in the development and optimisation of anti-angiogenic (anti-blood vessel) drugs for the treatment of ovarian cancer. His research has been widely published in peer-reviewed journals, and he is frequently invited to speak at international conferences.
Roles and Interests
- Chair of Translational Research for the Medical Research Council ICON7
- Chair of the Manchester Cancer Systemic Anti-Cancer Therapy Board
Procedures and Conditions Treated
- Chemotherapy
- Endometrial Cancer
- Gynaecological Cancers
- Ovarian Cancer
Prof. Jayson has been a pivotal figure in the field of medical oncology since his appointment in 1997, contributing significantly to both clinical practice and research.
Areas of expertise
- Medical oncology
- Gynaecological cancer
Professional memberships
Articles by Prof. Gordon Jayson
Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (icon6): overall survival results of a phase iii randomised trial
Image contrast, image pre-processing, and t1 mapping affect mri radiomic feature repeatability in patients with colorectal cancer liver metastases
High emsy expression defines a brca‐like subgroup of high‐grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum
Palliative home parenteral nutrition in patients with ovarian cancer and malignant bowel obstruction: experiences of women and family caregivers
Plasma tie2 is a tumor vascular response biomarker for vegf inhibitors in metastatic colorectal cancer
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity
Dealing with loss: food and eating in women with ovarian cancer on parenteral nutrition
Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer
First-line management of advanced high-grade serous ovarian cancer
